Translational Vaccinology for Global Health
October 26 - 30 2016
Park Plaza Riverbank London, London, United Kingdom
The time required to launch new global health vaccines is too long and the late failure rate is unsustainably high. Key barriers include insufficient diversity and quality of preclinical concepts and candidates, immunobiological ignorance, and a lack of understanding of correlates or mechanisms of protection. Root causes include siloed science and linear thinking; poor integration across the discovery/development/delivery ecosystem; and slow entry and limited throughput in early human proof of concept testing. This Keystone Symposia meeting aims to bring together those pioneering novel, creative solutions to these problems of global vaccine discovery and development across the academic/biotech/product development partner/pharma spectrum.
Organized by Drs. Christopher L. Karp of the Bill & Melinda Gates Foundation, USA, Gagandeep Kang of Christian Medical College, India, and Rino Rappuoli of GlaxoSmithKline Vaccines, Italy, the four-day conference aims to:
- Present and discuss the most current and cutting-edge scientific knowledge in global health vaccine discovery and development, covering newest technologies and experimental approaches, as well as discussions of how to accelerate their vaccine concept and candidate de-risking, up- and down-selection, and proof-of-concept testing and efficacy testing
- Consider the future directions of the field, including identification of the most pressing unanswered questions, the areas needing more focus, and the areas that would benefit from new approaches and methodologies developed and used in other related fields
- Stimulate collaborations by providing a setting conducive to focused, intense discussion among basic immunologists, microbiologists and translational vaccinologists in academia, the biotech world and pharma
Short talk speakers will be chosen from all submitted abstracts.
Session topics include:
- Controlled Human Infection Models
- Workshop 1: Correlates of Protection
- Human Immune Profiling
- Toward PK/PD in B cell Vaccinology
- Workshop 2: Human Immunophenotyping
- Novel Appraoches to Antigen Identification and Immunogen Design
- Adjuvants, Mucosal and Otherwise
- Clinical Trial Readouts
- Workshop 3: Antigen Identification, Adjuvants, Formulations and Novel Delivery Platforms
- Accelerating Global Health Vaccine R&D
Deadlines
- Scholarship Deadline Jun 27, 2016
- Discounted Abstract Deadline Jun 27, 2016
- Abstract Deadline Jul 26, 2016
- Discounted Registration Deadline Aug 25, 2016